Drug Availability

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

There has been concern about drug shortages during the COVID-19 pandemic. The CLL Society investigated these concerns and has been reassured that, at least for ibrutinib, there will be no impacts to the product supply.